The pro-inflammatory molecule, AIF1, is also associated with the development of atherosclerosis and is expressed primarily in the monocyte/macrophage (MP) lineage, and is a positive regulator of the NF-κB pathway (23). Here, NFKB1 is linked to atherosclerosis.